Cardiovascular Risk The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, found that testosterone replacement did not increase the rate of major adverse cardiovascular events in middle-aged and older men with hypogonadism and high cardiovascular risk (HR 1.02, 95% CI 0.84 to 1.24)
Ex vivo study Human scalp tissue culture Human scalp tissue was obtained with approval from the Global Medical Research Center Institutional Review Board (IRB No
Wardlaw reports being part funded by the United Kingdom (UK) Dementia Research Institute which receives its funding from the UK Medical Research Council (MRC), Alzheimer's Society and Alzheimers Research UK
Beauty White is an all-in-one capsule packed with collagen, glutathione, vitamin c, and alpha-lipoic acid
The compounds low oral bioavailability and limited ability to cross the blood-brain barrier are challenges that still need to be addressed